Gynecologic Cancer
Feature
‘A good and peaceful death’: Cancer hospice during the pandemic
Conference Coverage
Secondary surgery extends OS in recurrent ovarian cancer
Cytoreductive surgery provided a significant survival benefit over chemotherapy alone for patients with favorable presurgical predictive scores....
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
Conference Coverage
Moving on up: Maintenance therapy extends OS in bladder cancer
Opinion
Should all patients with advanced ovarian cancer receive frontline maintenance therapy?
Is maintenance therapy worthwhile for all patients, and is it good value?
News
Oncologists’ income and satisfaction are up
Conference Coverage
New OS data with olaparib support ‘new era’ for ovarian cancer
Conference Coverage
Video coaching may relieve anxiety and distress for long-distance cancer caregivers
Conference Coverage
One strikeout, one hit against low-grade serous carcinomas
News from the FDA/CDC
FDA approves olaparib/bevacizumab maintenance
Conference Coverage
ASCO goes ahead online, as conference center is used as hospital